Primary Site >> Stomach Cancer
Gene >> CYP2A6
| 1. | |||||||||||
| Journal: | Pharmacogenetics. 2002 Jun;12(4):299-306. | ||||||||||
| Title: | A novel mutant allele of the CYP2A6 gene (CYP2A6*11 ) found in a cancer patient who showed poor metabolic phenotype towards tegafur. | ||||||||||
| Author: | Daigo, Satoshi|Takahashi, Yoshiki|Fujieda, Masaki|Ariyoshi, Noritaka|Yamazaki, Hiroshi|Koizumi, Wasaburo|Tanabe, Satoshi|Saigenji, Katsunori|Nagayama, Sekio|Ikeda, Kazumasa|Nishioka, Yasuhiko|Kamataki, Tetsuya | ||||||||||
| PMID: | 12042667 | ||||||||||
| 2. | |||||||||||
| Journal: | Int J Cancer. 2002 Aug 1;100(4):425-8. | ||||||||||
| Title: | Effects of cytochrome P450 (CYP) 2A6 gene deletion and CYP2E1 genotypes on gastric adenocarcinoma. | ||||||||||
| Author: | Tsukino, Hiromasa|Kuroda, Yoshiki|Qiu, Delai|Nakao, Hiroyuki|Imai, Hirohisa|Katoh, Takahiko | ||||||||||
| PMID: | 12115524 | ||||||||||
| 3. | |||||||||||
| Journal: | J Clin Oncol. 2005 Oct 1;23(28):6957-65. | ||||||||||
| Title: | Phase I pharmacokinetic study of S-1 plus cisplatin in patients with advanced gastric carcinoma. | ||||||||||
| Author: | Ajani, Jaffer A|Faust, Josephine|Ikeda, Kazumasa|Yao, James C|Anbe, Hiroshi|Carr, Kelli L|Houghton, Michele|Urrea, Peter | ||||||||||
| PMID: | 16145066 | ||||||||||
| 4. | |||||||||||
| Journal: | Gan To Kagaku Ryoho. 2006 Jun;33 Suppl 1:117-20. | ||||||||||
| Title: | Rapid development of S-1 in the west for therapy of advanced gastric carcinoma. | ||||||||||
| Author: | Ajani, Jaffer A | ||||||||||
| PMID: | 16897985 | ||||||||||
| 5. | |||||||||||
| Journal: | Int J Clin Oncol. 2008 Jun;13(3):206-11. | ||||||||||
| Title: | Challenges in predicting the clinical outcome in S-1-based chemotherapy for gastric cancer patients. | ||||||||||
| Author: | Ichikawa, Wataru|Sasaki, Yasutsuna | ||||||||||
| PMID: | 18553229 | ||||||||||
| 6. | |||||||||||
| Journal: | Int J Oncol. 2009 Mar;34(3):787-96. | ||||||||||
| Title: | Copy number changes can be a predictor for hemoglobin reduction after S-1 monotherapy in gastric cancer. | ||||||||||
| Author: | Jeung, Hei Cheul|Rha, Sun Young|Park, Chan Hee|Im, Chong-Kun|Shin, Sang Joon|Ahn, Joong Bae|Noh, Sung Hoon|Roh, Jae Kyung|Chung, Hyun Cheol | ||||||||||
| PMID: | 19212683 | ||||||||||
| 7. | |||||||||||
| Journal: | Future Oncol. 2011 Jun;7(6):715-26. | ||||||||||
| Title: | A comprehensive review of S-1 in the treatment of advanced gastric adenocarcinoma. | ||||||||||
| Author: | Blum, Mariela|Suzuki, Akihiro|Ajani, Jaffer A | ||||||||||
| PMID: | 21675835 | ||||||||||
| 8. | |||||||||||
| Journal: | Cancer Chemother Pharmacol. 2013 Nov;72(5):953-64. | ||||||||||
| Title: | Phase I clinical and pharmacokinetic/pharmacogenetic study of a triplet regimen of S-1/irinotecan/oxaliplatin in patients with metastatic colorectal or gastric cancer. | ||||||||||
| Author: | Park, Sook Ryun|Hong, Yong Sang|Lim, Hyeong-Seok|Seong, Moon-Woo|Kong, Sun-Young|Kim, Sun Young|Park, Young-Iee|Jung, Kyung Hae | ||||||||||
| PMID: | 23982118 | ||||||||||
| 9. | |||||||||||
| Journal: | Mol Clin Oncol. 2014 Jan;2(1):93-98. | ||||||||||
| Title: | Dose-finding study on adjuvant chemotherapy with S-1 plus oxaliplatin for gastric cancer. | ||||||||||
| Author: | Yang, Lin|Yang, Yi|Qin, Qiong|Zhou, Aiping|Zhao, Jianjun|Wang, Jinwan|Shu, Chang|Yuan, Xinghua|Hu, Songnian | ||||||||||
| PMID: | 24649314 | ||||||||||
| 10. | |||||||||||
| Journal: | PLoS One. 2015 Jul 16;10(7):e0131793. | ||||||||||
| Title: | The Effect of 5-Aminolevulinic Acid on Cytochrome P450-Mediated Prodrug Activation. | ||||||||||
| Author: | Miura, Mai|Ito, Kensuke|Hayashi, Maiko|Nakajima, Motowo|Tanaka, Tohru|Ogura, Shun-ichiro | ||||||||||
| PMID: | 26181717 | ||||||||||
| 11. | |||||||||||
| Journal: | Gastric Cancer. 2016 Apr;19(2):586-96. | ||||||||||
| Title: | A phase II study of perioperative S-1 combined with weekly docetaxel in patients with locally advanced gastric carcinoma: clinical outcomes and clinicopathological and pharmacogenetic predictors for survival. | ||||||||||
| Author: | Kim, Young-Woo|Kim, Mi-Jung|Ryu, Keun Won|Lim, Hyeong-Seok|Lee, Jun Ho|Kong, Sun-Young|Lee, Jong Seok|Choi, Il Ju|Kim, Chan Gyoo|Lee, Jong Yeul|Cho, Soo-Jeong|Kook, Myeong-Cherl|Park, Young-Iee|Kim, Seok-Ki|Park, Sook Ryun | ||||||||||
| PMID: | 25851942 | ||||||||||
| 12. | |||||||||||
| Journal: | Gastric Cancer. 2017 Jan;20(1):146-155. | ||||||||||
| Title: | Associations between CYP2A6 polymorphisms and outcomes of adjuvant S-1 chemotherapy in patients with curatively resected gastric cancer. | ||||||||||
| Author: | Jeong, Jae Ho|Park, Sook Ryun|Ahn, Yongchel|Ryu, Min-Hee|Ryoo, Baek-Yeol|Kong, Sun-Young|Yook, Jeong Hwan|Yoo, Moon-Won|Kim, Beom Su|Kim, Byung Sik|Kang, Yoon-Koo | ||||||||||
| PMID: | 26715117 | ||||||||||
| 13. | |||||||||||
| Journal: | Cancer Chemother Pharmacol. 2017 Jan;79(1):69-79. | ||||||||||
| Title: | Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway. | ||||||||||
| Author: | He, Ming-Ming|Zhang, Dong-Sheng|Wang, Feng|Wang, Zi-Xian|Yuan, Shu-Qiang|Wang, Zhi-Qiang|Luo, Hui-Yan|Ren, Chao|Qiu, Miao-Zhen|Jin, Ying|Wang, De-Shen|Chen, Dong-Liang|Zeng, Zhao-Lei|Li, Yu-Hong|He, Yang-Yang|Hao, Yuan-Tao|Guo, Pi|Wang, Feng-Hua|Zeng, Yi- | ||||||||||
| PMID: | 27913881 | ||||||||||
| 14. | |||||||||||
| Journal: | Genomics Proteomics Bioinformatics. 2017 Aug;15(4):255-262. | ||||||||||
| Title: | CYP2A6 Polymorphisms Associate with Outcomes of S-1 Plus Oxaliplatin Chemotherapy in Chinese Gastric Cancer Patients. | ||||||||||
| Author: | Yang, Lin|Zou, Shanshan|Shu, Chang|Song, Yan|Sun, Yong-Kun|Zhang, Wen|Zhou, Aiping|Yuan, Xinghua|Yang, Yi|Hu, Songnian | ||||||||||
| PMID: | 28811232 | ||||||||||
| 15. | |||||||||||
| Journal: | Zhonghua Yi Xue Za Zhi. 2018 Jun 26;98(24):1915-1918. | ||||||||||
| Title: | [The influence of CYP2A6 polymorphism on adjuvant S-1 chemotherapy outcomes in patients with curatively resected gastric cancer]. | ||||||||||
| Author: | Hu, F K|Shen, J|Gao, S W | ||||||||||
| PMID: | 29996281 | ||||||||||